Cargando…

Levels of ankle–brachial index and the risk of diabetes mellitus complications

OBJECTIVE: We sought to compare the association of categorized ankle–brachial index (ABI) with mortality and complications of diabetes in persons with no symptoms of peripheral arterial disease (PAD) and in primary cardiovascular disease prevention. RESEARCH DESIGN AND METHODS: This is a retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves-Cabratosa, Lia, Comas-Cufí, Marc, Ponjoan, Anna, Garcia-Gil, Maria, Martí-Lluch, Ruth, Blanch, Jordi, Elosua-Bayes, Marc, Parramon, Dídac, Camós, Lourdes, Guzmán, Lidia, Ramos, Rafel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059529/
https://www.ncbi.nlm.nih.gov/pubmed/32144131
http://dx.doi.org/10.1136/bmjdrc-2019-000977
_version_ 1783504068229988352
author Alves-Cabratosa, Lia
Comas-Cufí, Marc
Ponjoan, Anna
Garcia-Gil, Maria
Martí-Lluch, Ruth
Blanch, Jordi
Elosua-Bayes, Marc
Parramon, Dídac
Camós, Lourdes
Guzmán, Lidia
Ramos, Rafel
author_facet Alves-Cabratosa, Lia
Comas-Cufí, Marc
Ponjoan, Anna
Garcia-Gil, Maria
Martí-Lluch, Ruth
Blanch, Jordi
Elosua-Bayes, Marc
Parramon, Dídac
Camós, Lourdes
Guzmán, Lidia
Ramos, Rafel
author_sort Alves-Cabratosa, Lia
collection PubMed
description OBJECTIVE: We sought to compare the association of categorized ankle–brachial index (ABI) with mortality and complications of diabetes in persons with no symptoms of peripheral arterial disease (PAD) and in primary cardiovascular disease prevention. RESEARCH DESIGN AND METHODS: This is a retrospective cohort study of persons with type 2 diabetes aged 35–85 years, from 2006 to 2011. Data were obtained from the Sistema d'Informació per al Desenvolupament de la Investigació en Atenció Primària (SIDIAP(Q)). Participants had an ABI measurement that was classified into six categories. For each category of ABI, we assessed the incidence of mortality; macrovascular complications of diabetes: acute myocardial infarction (AMI), ischemic stroke, and a composite of these two; and microvascular complications of this metabolic condition: nephropathy, retinopathy, and neuropathy. We also estimated the HRs for these outcomes by ABI category using Cox proportional hazards models. RESULTS: Data from 34 689 persons with type 2 diabetes were included. The mean age was 66.2; 51.5% were men; and the median follow-up was 6.0 years. The outcome with the highest incidence was nephropathy, with 24.4 cases per 1000 person-years in the reference category of 1.1≤ABI≤1.3. The incidences in this category for mortality and AMI were 15.4 and 4.1, respectively. In the Cox models, low ABI was associated with increased risk and was significant from ABI lower than 0.9; below this level, the risk kept increasing steeply. High ABI (over 1.3) was also associated with significant increased risk for most outcomes. CONCLUSIONS: The studied categories of ABI were associated with different risks of type 2 diabetes complications in persons asymptomatic for PAD, who were in primary cardiovascular prevention. These findings could be useful to optimize preventive interventions according to the ABI category in this population.
format Online
Article
Text
id pubmed-7059529
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-70595292020-03-20 Levels of ankle–brachial index and the risk of diabetes mellitus complications Alves-Cabratosa, Lia Comas-Cufí, Marc Ponjoan, Anna Garcia-Gil, Maria Martí-Lluch, Ruth Blanch, Jordi Elosua-Bayes, Marc Parramon, Dídac Camós, Lourdes Guzmán, Lidia Ramos, Rafel BMJ Open Diabetes Res Care Cardiovascular and Metabolic Risk OBJECTIVE: We sought to compare the association of categorized ankle–brachial index (ABI) with mortality and complications of diabetes in persons with no symptoms of peripheral arterial disease (PAD) and in primary cardiovascular disease prevention. RESEARCH DESIGN AND METHODS: This is a retrospective cohort study of persons with type 2 diabetes aged 35–85 years, from 2006 to 2011. Data were obtained from the Sistema d'Informació per al Desenvolupament de la Investigació en Atenció Primària (SIDIAP(Q)). Participants had an ABI measurement that was classified into six categories. For each category of ABI, we assessed the incidence of mortality; macrovascular complications of diabetes: acute myocardial infarction (AMI), ischemic stroke, and a composite of these two; and microvascular complications of this metabolic condition: nephropathy, retinopathy, and neuropathy. We also estimated the HRs for these outcomes by ABI category using Cox proportional hazards models. RESULTS: Data from 34 689 persons with type 2 diabetes were included. The mean age was 66.2; 51.5% were men; and the median follow-up was 6.0 years. The outcome with the highest incidence was nephropathy, with 24.4 cases per 1000 person-years in the reference category of 1.1≤ABI≤1.3. The incidences in this category for mortality and AMI were 15.4 and 4.1, respectively. In the Cox models, low ABI was associated with increased risk and was significant from ABI lower than 0.9; below this level, the risk kept increasing steeply. High ABI (over 1.3) was also associated with significant increased risk for most outcomes. CONCLUSIONS: The studied categories of ABI were associated with different risks of type 2 diabetes complications in persons asymptomatic for PAD, who were in primary cardiovascular prevention. These findings could be useful to optimize preventive interventions according to the ABI category in this population. BMJ Publishing Group 2020-03-05 /pmc/articles/PMC7059529/ /pubmed/32144131 http://dx.doi.org/10.1136/bmjdrc-2019-000977 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Cardiovascular and Metabolic Risk
Alves-Cabratosa, Lia
Comas-Cufí, Marc
Ponjoan, Anna
Garcia-Gil, Maria
Martí-Lluch, Ruth
Blanch, Jordi
Elosua-Bayes, Marc
Parramon, Dídac
Camós, Lourdes
Guzmán, Lidia
Ramos, Rafel
Levels of ankle–brachial index and the risk of diabetes mellitus complications
title Levels of ankle–brachial index and the risk of diabetes mellitus complications
title_full Levels of ankle–brachial index and the risk of diabetes mellitus complications
title_fullStr Levels of ankle–brachial index and the risk of diabetes mellitus complications
title_full_unstemmed Levels of ankle–brachial index and the risk of diabetes mellitus complications
title_short Levels of ankle–brachial index and the risk of diabetes mellitus complications
title_sort levels of ankle–brachial index and the risk of diabetes mellitus complications
topic Cardiovascular and Metabolic Risk
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059529/
https://www.ncbi.nlm.nih.gov/pubmed/32144131
http://dx.doi.org/10.1136/bmjdrc-2019-000977
work_keys_str_mv AT alvescabratosalia levelsofanklebrachialindexandtheriskofdiabetesmellituscomplications
AT comascufimarc levelsofanklebrachialindexandtheriskofdiabetesmellituscomplications
AT ponjoananna levelsofanklebrachialindexandtheriskofdiabetesmellituscomplications
AT garciagilmaria levelsofanklebrachialindexandtheriskofdiabetesmellituscomplications
AT martilluchruth levelsofanklebrachialindexandtheriskofdiabetesmellituscomplications
AT blanchjordi levelsofanklebrachialindexandtheriskofdiabetesmellituscomplications
AT elosuabayesmarc levelsofanklebrachialindexandtheriskofdiabetesmellituscomplications
AT parramondidac levelsofanklebrachialindexandtheriskofdiabetesmellituscomplications
AT camoslourdes levelsofanklebrachialindexandtheriskofdiabetesmellituscomplications
AT guzmanlidia levelsofanklebrachialindexandtheriskofdiabetesmellituscomplications
AT ramosrafel levelsofanklebrachialindexandtheriskofdiabetesmellituscomplications